Guidelines & Advice

Head & Neck Cancer

These guidelines and other documents provide advice for different types of head and neck cancer: larynx, salivary glands, pharynx, oral, nasopharynx and paranasal sinus.

Displaying Guidelines

26 Items

PET Imaging in Head and Neck Cancer

Document Status: Current
ID: PET 2
Version: 2

Feb 2012

Radionuclide Therapy for Patients with Neuroendocrine Tumors (NETs) in Ontario: Expert Panel Report

Document Status: Current
ID: GL-C50-01

Jan 2011

Recombinant Humanized Thyroid Stimulating Hormone (rhTSH) Preparation Prior To Radioiodine Ablation in Patients Who Have Undergone Thyroidectomy for Papillary or Follicular Thyroid Cancer

Document Status: Archived
ID: CED 5

May 2007

Routine Human Papilloma Virus (HPV) Testing in Squamous Cell Head and Neck Cancer

Document Status: Current
ID: 5-9
Version: 2

Jan 2020

Surgical, Radiation, and Systemic Treatments of Patients with Thymic Epithelial Tumours

Document Status: Current
ID: 7-11
Version: 3

Mar 2022

Symptomatic Treatment of Radiation-Induced Xerostomia in Head and Neck Cancer Patients

Document Status: Archived
ID: 5-5

Mar 2004

Systemic therapy for unresectable advanced or metastatic pancreatic and midgut neuroendocrine tumours

Document Status: Current
ID: GL 2-21
Version: 2

Mar 2024

Systemic Therapy in the Curative Treatment of Head and Neck Squamous Cell Cancer

Document Status: Current
ID: 5-11
Version: 2

Jan 2022

The Management of Head and Neck Cancer in Ontario

Document Status: Archived
ID: 5-3

Dec 2009

The Role of Amifostine as a Radioprotectant in the Management of Patients with Squamous Cell Head and Neck Cancer

Document Status: Archived
ID: 5-8

Apr 2012

The Role of Endolaryngeal Surgery (With or Without Laser) versus Radiotherapy in the Management of Early (T1) Glottic Cancer

Document Status: Current
ID: 5-2
Version: 2

Oct 2023

The Role of IMRT in Head and Neck Cancer

Document Status: Archived
ID: 21-3-3

Jan 2011